Main content area

Development and validation of an UHPLC-HRMS protocol for the analysis of flavan-3-ol metabolites and catabolites in urine, plasma and feces of rats fed a red wine proanthocyanidin extract

Pereira-Caro, Gema, Ordóñez, José Luis, Ludwig, Iziar, Gaillet, Sylvie, Mena, Pedro, Del Rio, Daniele, Rouanet, Jean-Max, Bindon, Keren A., Moreno-Rojas, José Manuel, Crozier, Alan
Food chemistry 2018 v.252 pp. 49-60
bioavailability, clinical trials, detection limit, feces, flavanols, humans, ingestion, liquids, mass spectrometry, metabolites, proanthocyanidins, rats, red wines, urine
This study developed, optimized and validated an ultra-high-performance liquid chromatography–high-resolution mass spectrometry (UHPLC-HRMS) method to identify and quantify metabolites and microbial-derived catabolites in urine, plasma and feces of rats following ingestion of 50 mg of a red wine proanthocyanidin-rich extract. The method was validated for specificity, linearity, limit of detection (LD) and quantification (LQ), intra-day and inter-day precision, recovery and matrix effects, which were determined for 34 compounds in the three biological matrices. After method validation, three parent flavan-3-ols, four 5-carbon side chain ring fission metabolites, and 27 phenolic acid and aromatic catabolites were quantified in plasma, urine and feces after red wine proanthocyanidin intake. These results establish the value of the UHPLC-HRMS protocol in obtaining a detailed picture of proanthocyanidin metabolites and their microbial-derived catabolites, along with their phase II metabolites, in biological fluids of rat, and potentially in human clinical studies designed to evaluate the bioavailability of dietary flavan-3-ols.